BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leowattana W, Leowattana T, Leowattana P. Systemic treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 2023; 29(10): 1551-1568 [PMID: 36970588 DOI: 10.3748/wjg.v29.i10.1551]
URL: https://www.wjgnet.com/1007-9327/full/v29/i10/1551.htm
Number Citing Articles
1
Shahad A Alshehri, Wasayf A Almarwani, Ajwan Z Albalawi, Shekha M Al-atwi, Khulud K Aljohani, Amjad A Alanazi, Mohamed A Ebrahim, Hanan M Hassan, Mohammed M Al-Gayyar. Role of Arctiin in Fibrosis and Apoptosis in Experimentally Induced Hepatocellular Carcinoma in RatsCureus 2024;  doi: 10.7759/cureus.51997
2
Shui Liu, Qiao Li, Yongzhi Li, Jiyao Sheng. Editorial: Advances in chemotherapy-resistant hepatocellular carcinomaFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1325304
3
Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, Xiang-Shuo Kong. A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1159286
4
Manisri Porukala, P. K. Vinod, Amy McCart Reed. Gene expression signatures of stepwise progression of Hepatocellular CarcinomaPLOS ONE 2023; 18(12): e0296454 doi: 10.1371/journal.pone.0296454
5
Ryo Yano, Masashi Hirooka, Yoshiko Nakamura, Yusuke Imai, Yohei Koizumi, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa. A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administrationClinical Journal of Gastroenterology 2024; 17(2): 319 doi: 10.1007/s12328-023-01914-7